Go Pro
NASDAQ:PRVA

Privia Health Group (PRVA) Stock Price, News & Analysis

Privia Health Group logo
$22.12 -0.33 (-1.45%)
As of 02:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Privia Health Group Stock (NASDAQ:PRVA)

Advanced

Key Stats

Today's Range
$22.05
$22.81
50-Day Range
$20.66
$28.10
52-Week Range
$19.53
$28.82
Volume
443,365 shs
Average Volume
989,244 shs
Market Capitalization
$2.83 billion
P/E Ratio
105.36
Dividend Yield
N/A
Price Target
$31.00
Consensus Rating
Moderate Buy

Company Overview

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States. The company’s network encompasses employed and affiliated physicians in primary care and a range of specialties, enabling collaborative care delivery and streamlined administrative processes for more than 500,000 patients annually.

Privia Health’s core offerings include care management services, performance analytics, patient engagement tools and revenue cycle management solutions. Its technology-enabled platform aggregates clinical and financial data in real time, helping physicians identify high-risk patients, track quality metrics and coordinate care across the continuum. By aligning incentives with payers and employers, Privia supports value-based arrangements that reward improved outcomes and cost efficiency.

Co-founder and Chief Executive Officer Irad Kaufman leads Privia Health’s executive team, drawing on extensive experience in healthcare strategy and operations. Under his leadership, the company continues to expand its integrated network, deepen payer partnerships and refine its technology platform to meet evolving industry demands.

AI Generated. May Contain Errors.

Privia Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
96th Percentile Overall Score

PRVA MarketRank™: 

Privia Health Group scored higher than 96% of companies evaluated by MarketBeat, and ranked 20th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Privia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on no strong buy ratings, 11 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Privia Health Group has a consensus price target of $31.00, representing about 40.3% upside from its current price of $22.10.

  • Amount of Analyst Coverage

    Privia Health Group has only been the subject of 4 research reports in the past 90 days.

  • Read more about Privia Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Privia Health Group are expected to grow by 57.69% in the coming year, from $0.26 to $0.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Privia Health Group is 105.70, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.47.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Privia Health Group is 105.70, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 269.93.

  • Price to Earnings Growth Ratio

    Privia Health Group has a PEG Ratio of 1.81. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Privia Health Group has a P/B Ratio of 3.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.10% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 3.32, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Privia Health Group has recently decreased by 0.94%, indicating that investor sentiment is improving.
  • Dividend Yield

    Privia Health Group does not currently pay a dividend.

  • Dividend Growth

    Privia Health Group does not have a long track record of dividend growth.

  • News Sentiment

    Privia Health Group has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Privia Health Group this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for PRVA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,436,655.00 in company stock.

  • Percentage Held by Insiders

    5.70% of the stock of Privia Health Group is held by insiders.

  • Percentage Held by Institutions

    94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Privia Health Group's insider trading history.
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRVA Stock News Headlines

BMO Capital Keeps Their Buy Rating on Privia Health Group (PRVA)
Evercore ISI Remains a Buy on Privia Health Group (PRVA)
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capital - the firm behind Anthropic and OpenAI - calls it a 'holy grail.' It's smaller than a fingertip and made of glass. Wall Street insider Jason Bodner - who called Nvidia at $4.50 - believes this 'light-speed' device could be bigger for AI than GPUs and is about to launch a new wave of winners. He's sharing his number one stock pick tied to it at no cost.tc pixel
Privia Health earnings call highlights growth and margins
See More Headlines

PRVA Stock Analysis - Frequently Asked Questions

Privia Health Group's stock was trading at $23.71 at the start of the year. Since then, PRVA shares have decreased by 6.8% and is now trading at $22.0950.

Privia Health Group, Inc. (NASDAQ:PRVA) posted its quarterly earnings results on Thursday, February, 26th. The company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.21. The business's quarterly revenue was up 17.4% on a year-over-year basis.
Read the conference call transcript
.

Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Top institutional investors of Privia Health Group include BlackRock Inc. (16.98%), Bank of New York Mellon Corp (2.30%), OneDigital Investment Advisors LLC (0.21%) and Deutsche Bank AG (0.19%). Insiders that own company stock include Adam Boehler, William M Sullivan, Parth Mehrotra, David Mountcastle, Thomas Bartrum, Edward C Fargis, Matthew Shawn Morris and Thomas A Mccarthy.
View institutional ownership trends
.

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
2/26/2026
Today
8/10/2026
Investor presentation
8/10/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:PRVA
CIK
1759655
Fax
N/A
Employees
1,226
Year Founded
2007

Price Target and Rating

High Price Target
$36.00
Low Price Target
$24.00
Potential Upside/Downside
+40.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.21
Trailing P/E Ratio
105.36
Forward P/E Ratio
85.10
P/E Growth
1.81
Net Income
$22.92 million
Net Margins
1.19%
Pretax Margin
2.38%
Return on Equity
3.52%
Return on Assets
2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.62
Quick Ratio
1.62

Sales & Book Value

Annual Sales
$2.12 billion
Price / Sales
1.33
Cash Flow
$0.26 per share
Price / Cash Flow
84.12
Book Value
$6.43 per share
Price / Book
3.44

Miscellaneous

Outstanding Shares
127,730,000
Free Float
120,453,000
Market Cap
$2.83 billion
Optionable
Optionable
Beta
0.85

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:PRVA) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners